Fred Alger Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-134
Closed -$21K 526
2020
Q4
$21K Hold
134
﹤0.01% 445
2020
Q3
$15K Sell
134
-30,646
-100% -$3.43M ﹤0.01% 446
2020
Q2
$3.46M Sell
30,780
-15,693
-34% -$1.76M 0.01% 261
2020
Q1
$4.17M Sell
46,473
-77,062
-62% -$6.92M 0.02% 222
2019
Q4
$13.4M Buy
+123,535
New +$13.4M 0.05% 188
2019
Q3
Sell
-82,343
Closed -$10.8M 558
2019
Q2
$10.8M Sell
82,343
-76,668
-48% -$10M 0.04% 182
2019
Q1
$21.5M Buy
159,011
+153,305
+2,687% +$20.7M 0.09% 164
2018
Q4
$556K Sell
5,706
-12,394
-68% -$1.21M ﹤0.01% 348
2018
Q3
$2.52M Sell
18,100
-5,992
-25% -$833K 0.01% 268
2018
Q2
$2.99M Buy
24,092
+178
+0.7% +$22.1K 0.01% 258
2018
Q1
$2.67M Buy
23,914
+3,814
+19% +$425K 0.01% 274
2017
Q4
$2.4M Sell
20,100
-69,997
-78% -$8.37M 0.01% 275
2017
Q3
$12.6M Sell
90,097
-58,600
-39% -$8.22M 0.06% 167
2017
Q2
$18.1M Sell
148,697
-465,964
-76% -$56.7M 0.09% 145
2017
Q1
$74.5M Sell
614,661
-120,090
-16% -$14.6M 0.37% 70
2016
Q4
$89.9M Buy
734,751
+248,816
+51% +$30.4M 0.49% 52
2016
Q3
$59.5M Buy
485,935
+406,204
+509% +$49.8M 0.31% 69
2016
Q2
$9.31M Buy
79,731
+76,681
+2,514% +$8.95M 0.05% 172
2016
Q1
$425K Sell
3,050
-39,617
-93% -$5.52M ﹤0.01% 425
2015
Q4
$8.14M Sell
42,667
-40,921
-49% -$7.81M 0.04% 203
2015
Q3
$13.1M Buy
+83,588
New +$13.1M 0.07% 157
2015
Q2
Sell
-58,043
Closed -$10.1M 553
2015
Q1
$10.1M Sell
58,043
-8,019
-12% -$1.39M 0.05% 265
2014
Q4
$12.2M Sell
66,062
-13,935
-17% -$2.58M 0.06% 235
2014
Q3
$13.3M Buy
79,997
+29,599
+59% +$4.91M 0.06% 215
2014
Q2
$7.88M Sell
50,398
-64,985
-56% -$10.2M 0.04% 322
2014
Q1
$17.6M Sell
115,383
-49,625
-30% -$7.55M 0.09% 224
2013
Q4
$21.9M Sell
165,008
-19,743
-11% -$2.62M 0.11% 202
2013
Q3
$21.5M Buy
184,751
+36,653
+25% +$4.26M 0.12% 192
2013
Q2
$13.7M Buy
+148,098
New +$13.7M 0.08% 244